NLS Pharmaceutics AG Statistics
Total Valuation
NLSP has a market cap or net worth of $5.61 million. The enterprise value is $6.12 million.
Important Dates
The next estimated earnings date is Friday, September 20, 2024, after market close.
| Earnings Date | Sep 20, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
NLSP has 43.42 million shares outstanding. The number of shares has increased by 93.96% in one year.
| Shares Outstanding | 43.42M |
| Shares Change (YoY) | +93.96% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 22.28% |
| Owned by Institutions (%) | 9.37% |
| Float | 22.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.23
| Current Ratio | 0.23 |
| Quick Ratio | 0.12 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -81.34 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -132.68% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.74M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -85.38% in the last 52 weeks. The beta is -0.57, so NLSP's price volatility has been lower than the market average.
| Beta (5Y) | -0.57 |
| 52-Week Price Change | -85.38% |
| 50-Day Moving Average | 0.18 |
| 200-Day Moving Average | 0.28 |
| Relative Strength Index (RSI) | 30.56 |
| Average Volume (20 Days) | 378,027 |
Short Selling Information
The latest short interest is 1.60 million, so 3.68% of the outstanding shares have been sold short.
| Short Interest | 1.60M |
| Short Previous Month | 3.83M |
| Short % of Shares Out | 3.68% |
| Short % of Float | 7.01% |
| Short Ratio (days to cover) | 0.26 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -11.81M |
| Pretax Income | -12.17M |
| Net Income | -12.17M |
| EBITDA | -11.80M |
| EBIT | -11.81M |
| Earnings Per Share (EPS) | -$0.32 |
Full Income StatementBalance Sheet
The company has $897,680 in cash and $1.63 million in debt, giving a net cash position of -$736,066 or -$0.02 per share.
| Cash & Cash Equivalents | 897,680 |
| Total Debt | 1.63M |
| Net Cash | -736,066 |
| Net Cash Per Share | -$0.02 |
| Equity (Book Value) | -8.83M |
| Book Value Per Share | -0.27 |
| Working Capital | -6.10M |
Full Balance SheetCash Flow
| Operating Cash Flow | -9.68M |
| Capital Expenditures | n/a |
| Free Cash Flow | -9.68M |
| FCF Per Share | -$0.22 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |